产品中心Cell Resources
联系我们CONTACT US
400-999-210024小时服务热线
产品概述
产品简介
产品说明
| 产品形态 | 液体 |
| 产品浓度 | 1× |
| 产品规格 | 125mL×4 |
| 培养基成分 | DMEM(PM150210)＋10% FBS(164210-50)＋1% P/S(PB180120) |
| 细菌检测 | 阴性 |
| 真菌检测 | 阴性 |
| 支原体检测 | 阴性 |
| 细胞生长实验 | 细胞生长良好，形态正常 |
| 内毒素含量(EU/mL) | ≤3 |
| 储存条件 | 2-8℃，避光储存 |
| 运输条件 | 冰袋冷藏运输 |
| 有效期 | 6个月 |
注意事项
参考文献
-
Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496/programmed cell death ligand 1 axis in an m6A-dependent manner (2024-03-28)
作者：Furong Yu:1.Department of Medical Technology, Anhui Medical College, Hefei, China. ; Peifei Fang:1.School of Basic Medicine, Anhui Medical College, Hefei, Anhi, China. ; Yonghong Fang:1.Department of Medical Technology, Anhui Medical College, Hefei, China. ; Daojun Chen:1.Department of Medical Technology, Anhui Medical College, Hefei, China. ;
期刊：Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR-496/programmed cell death ligand 1 axis in an m6A-dependent manner
影响因子 ：4.5
引用产品： MHCC97-L 细胞 , Hep 3B2.1-7 细胞 , HuH-7 细胞 , MHCC97-L细胞专用培养基 , Hep 3B2.1-7细胞专用培养基 , HuH-7细胞专用培养基
-
HuR-induced circ_0082319 contributes to hepatocellular carcinoma by elevating PTK2 through miR-505-3p (2023-10-25)
作者：Chuntang Qin:1.Department of Interventional, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Democratic South Road 17, Jiefang District, Jiaozuo, 454000, China. jzyueliangchuan@126.com. ; Shuyan Liu:1.Department of Endocrinology, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Jiaozuo, 454000, China. ; Weibin Chen:1.Department of Interventional, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Democratic South Road 17, Jiefang District, Jiaozuo, 454000, China. ; Dan Xue:1.Department of Interventional, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Democratic South Road 17, Jiefang District, Jiaozuo, 454000, China. ; Tianli Guo:1.Department of Interventional, The First Affiliated Hospital of Henan Polytechnic University (Jiaozuo Second People's Hospital), Democratic South Road 17, Jiefa
期刊：HuR-induced circ_0082319 contributes to hepatocellular carcinoma by elevating PTK2 through miR-505-3p
DOI：10.1007/s00210-023-02793-y
影响因子 ：3.6
引用产品： MHCC97-L 细胞 , Hep 3B2.1-7 细胞 , HuH-7 细胞 , MHCC97-L细胞专用培养基 , Hep 3B2.1-7细胞专用培养基 , HuH-7细胞专用培养基
-
LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation (2023-05-17)
作者：Bin Chen:1.Department of Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University, Zhejiang, Hangzhou 310011, China. ; Xin Xu:1.Department of Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University, Zhejiang, Hangzhou 310011, China. ; Wei Wu:1.Department of Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University, Zhejiang, Hangzhou 310011, China. ; Ke Zheng:1.Department of Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University, Zhejiang, Hangzhou 310011, China. ; Yijun Yu:1.Department of Hepatobiliary Surgery, The Affiliated Hospital of Hangzhou Normal University, Zhejiang, Hangzhou 310011, China. ;
期刊：LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation
影响因子 ：3.2
引用产品： Hep G2 细胞 , HuH-7 细胞 , Li-7 细胞 , HuH-7细胞专用培养基
-
Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p (2011-01-20)
作者：Lan Gao:1.Pharmacy Department, The People's Hospital of Xinchang, China. ; Xiufeng Zhang:1.Pharmacy Department, The People's Hospital of Xinchang, China. Electronic address: zhangxiufeng_zxf1@163.com. ;
期刊：Propofol enhances the lethality of cisplatin on liver cancer cells by up-regulating miR-195-5p
DOI：10.1016/j.tice.2021.101680
影响因子 ：2.6
引用产品： HuH-7 细胞 , Hep 3B2.1-7 细胞 , HuH-7细胞专用培养基 , Hep 3B2.1-7细胞专用培养基
-
Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma (2011-09-20)
作者：Fengkai Sun:1.Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jingwu Road 324#, Jinan, 250021, China. sunfengkai2016@126.com. ; Jianping Wang:1.Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China. ; Qi Sun:1.Department of General Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China. ; Fanni Li:1.Department of Talent Highland, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, Shaanxi, China. ; Hengjun Gao:1.Department of Hepatobiliary Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, 250021, Shandong, China. ; Lin Xu:1.Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jingwu Road 324#, Jinan, 250021, China. ; Jiao Zhang:1.Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong Univer
期刊：Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma
影响因子 ：11.3
引用产品： HuH-7细胞专用培养基 , Hep G2 细胞
FAQs
Q：{{item.question}}
A：
产品资料
识别码示意图
